BRPI0702622A8 - Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos - Google Patents

Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos

Info

Publication number
BRPI0702622A8
BRPI0702622A8 BRPI0702622A BRPI0702622A BRPI0702622A8 BR PI0702622 A8 BRPI0702622 A8 BR PI0702622A8 BR PI0702622 A BRPI0702622 A BR PI0702622A BR PI0702622 A BRPI0702622 A BR PI0702622A BR PI0702622 A8 BRPI0702622 A8 BR PI0702622A8
Authority
BR
Brazil
Prior art keywords
extracts
nardus
cymbopogon nardus
obtaining
pharmaceutical compositions
Prior art date
Application number
BRPI0702622A
Other languages
English (en)
Inventor
Lucy Franco Selma
Inez Estivalet Svidzinski Terezinha
Ester Nascimento Ogava Suzana
Original Assignee
Univ Estadual De Maringa
Apsen Farm S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Estadual De Maringa, Apsen Farm S A filed Critical Univ Estadual De Maringa
Priority to BRPI0702622A priority Critical patent/BRPI0702622A8/pt
Priority to UY30958A priority patent/UY30958A1/es
Priority to ARP080101041A priority patent/AR066188A1/es
Priority to CL200800743A priority patent/CL2008000743A1/es
Priority to JP2009553873A priority patent/JP2010521499A/ja
Priority to PCT/BR2008/000073 priority patent/WO2008113146A1/en
Priority to CA002681084A priority patent/CA2681084A1/en
Priority to MX2009009826A priority patent/MX2009009826A/es
Priority to AU2008229578A priority patent/AU2008229578A1/en
Priority to CN200880015450A priority patent/CN101730537A/zh
Priority to EP08714520A priority patent/EP2136828A4/en
Priority to NZ580053A priority patent/NZ580053A/xx
Publication of BRPI0702622A publication Critical patent/BRPI0702622A/pt
Priority to US12/561,170 priority patent/US20100047370A1/en
Publication of BRPI0702622A8 publication Critical patent/BRPI0702622A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composições farmacêuticas com atividade antífúngíca contendo extratos de Cymbopog-on nardus, processo de obtenção dos extratos de Cymbopogon nardus e seus usos. A presente invenção refere-se a aplicação de extratos de Cymlbopogon nardus no preparo de composições farmacêuticas com atividade aritífúngica e ao processo de obtenção dos referidos extratos, bem como o seu uso como componente ativo das referidas composições empregadas no tratamento de mícoses. A invenção também diz respeito às composições contendo o extrato vegetal obtido das partes aéreas de urna planta da família das Gramínae com atividade antífúngíca. Preferencíalmente o extrato vegetal é obtido das folhas da planta. Mais preferencialmente ainda a planta empregada é a Cymbopogon nardus (L.) Rendle.
BRPI0702622A 2007-03-16 2007-03-16 Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos BRPI0702622A8 (pt)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BRPI0702622A BRPI0702622A8 (pt) 2007-03-16 2007-03-16 Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos
UY30958A UY30958A1 (es) 2007-03-16 2008-03-12 Composiciones farmacéuticas con actividad antigungica conteniendo extractos de cymbopogon nardus, proceso de obtencion de extractos de cymbopogon nardus y usos.
ARP080101041A AR066188A1 (es) 2007-03-16 2008-03-13 Composiciones farmaceuticas con actividad antifungica conteniendo extractos de cymbopogon nardus proceso de obtencion de los extractos de cymbopogon nardus y sus usos
CL200800743A CL2008000743A1 (es) 2007-03-16 2008-03-13 Composiciones farmaceuticas con actividad antifungica que contienen extracto vegetal hidroalcoholico de cymbopogon nardus y por lo menos un solvente organico alcoholico de c1-c10 atomos de carbono; uso de los extractos para tratar onicomicosis, derma
MX2009009826A MX2009009826A (es) 2007-03-16 2008-03-14 Composicion farmaceutica con actividad antifungica que contiene cymbopogon nardus, su procedimiento y uso.
PCT/BR2008/000073 WO2008113146A1 (en) 2007-03-16 2008-03-14 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use
CA002681084A CA2681084A1 (en) 2007-03-16 2008-03-14 Pharmaceutical compositions with antifungal activity containing cymbopogon nardus extract, process of obtaining the extracts, and their use
JP2009553873A JP2010521499A (ja) 2007-03-16 2008-03-14 シトロネラエキスを含有する抗真菌活性を有する医薬組成物、シトロネラエキスの製造方法、及び、シトロネラエキスの使用
AU2008229578A AU2008229578A1 (en) 2007-03-16 2008-03-14 Pharmaceutical composition with antifungal activity containing Cymbopogon nardus, its process, and use
CN200880015450A CN101730537A (zh) 2007-03-16 2008-03-14 具有抗真菌活性的包含亚香茅的药物组合物、获得亚香茅的方法及其用途
EP08714520A EP2136828A4 (en) 2007-03-16 2008-03-14 CYMBOPOGON NARDUS PHARMACEUTICAL COMPOSITION WITH ANTIMYCOTIC EFFECT, ITS METHOD AND ITS USE
NZ580053A NZ580053A (en) 2007-03-16 2008-03-14 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use
US12/561,170 US20100047370A1 (en) 2007-03-16 2009-09-16 Pharmaceutical composition with antifungal activity containing cymbopogon nardus, its process, and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0702622A BRPI0702622A8 (pt) 2007-03-16 2007-03-16 Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos

Publications (2)

Publication Number Publication Date
BRPI0702622A BRPI0702622A (pt) 2008-11-04
BRPI0702622A8 true BRPI0702622A8 (pt) 2016-11-16

Family

ID=39472759

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0702622A BRPI0702622A8 (pt) 2007-03-16 2007-03-16 Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos

Country Status (13)

Country Link
US (1) US20100047370A1 (pt)
EP (1) EP2136828A4 (pt)
JP (1) JP2010521499A (pt)
CN (1) CN101730537A (pt)
AR (1) AR066188A1 (pt)
AU (1) AU2008229578A1 (pt)
BR (1) BRPI0702622A8 (pt)
CA (1) CA2681084A1 (pt)
CL (1) CL2008000743A1 (pt)
MX (1) MX2009009826A (pt)
NZ (1) NZ580053A (pt)
UY (1) UY30958A1 (pt)
WO (1) WO2008113146A1 (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60232157A (ja) * 1984-04-27 1985-11-18 菱沼　聖 死臭を消す寛永通宝六文銭
JPH0488069A (ja) * 1990-07-31 1992-03-19 Dainippon Printing Co Ltd 香料インキ
JP2000136141A (ja) * 1998-10-30 2000-05-16 Sumitomo Forestry Co Ltd 抗菌剤
DE10100811A1 (de) * 2001-01-10 2002-07-18 Walther Schoenenberger Pflanze Verwendung von ätherischen Ölen zur topischen Behandlung oder Prophylaxe von Wundheilungsstörungen
JP2003107004A (ja) * 2001-07-23 2003-04-09 Sanyo Electric Co Ltd ニオイ結合タンパク質の結合特性の改変方法、化学物質センサおよび化学物質の検出方法
KR100521783B1 (ko) * 2002-07-23 2005-10-14 주식회사 내츄로바이오텍 식물 추출물을 포함하는 항비듬균 조성물
GB0405545D0 (en) * 2004-03-12 2004-04-21 Univ Manchester Antimicrobial composition
AU2004201556A1 (en) * 2004-04-14 2005-10-27 Cini Organics Pty Limited Compositions and Methods for the Treatment of Skin Conditions
JP2006290872A (ja) * 2005-03-15 2006-10-26 Hirosaki Univ グラム陰性菌及びグラム陽性菌等に対する抗菌活性を呈する機能性イソプレノイド

Also Published As

Publication number Publication date
WO2008113146A1 (en) 2008-09-25
AU2008229578A1 (en) 2008-09-25
US20100047370A1 (en) 2010-02-25
BRPI0702622A (pt) 2008-11-04
CL2008000743A1 (es) 2008-09-26
JP2010521499A (ja) 2010-06-24
AR066188A1 (es) 2009-08-05
CA2681084A1 (en) 2008-09-25
EP2136828A1 (en) 2009-12-30
EP2136828A4 (en) 2010-06-23
MX2009009826A (es) 2009-11-23
NZ580053A (en) 2012-08-31
UY30958A1 (es) 2008-05-31
CN101730537A (zh) 2010-06-09

Similar Documents

Publication Publication Date Title
Shang et al. Leonurus japonicus Houtt.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine
Deresse Antibacterial Effect of Garlic (" Allium sativum") on" Staphylococcu aureus": An" in vitro" Study
Florentino et al. Antinociceptive and anti-inflammatory effects of Memora nodosa and allantoin in mice
MX2012010043A (es) Composiciones y metodos para aumentar biomasa, concentracion de hierro y tolerancia a patogenos en plantas.
Kumar et al. A review on chemical and biological properties of Cayratia trifolia Linn.(Vitaceae)
BR112015013056A2 (pt) uso de 1-(ariletinil)-, 1-(heteroariletinil)-, 1-(heterocicliletinil)- substituídos e 1-(cicloalqueniletinil)-bicicloalcanóis como agentes ativos contra o estresse abiótico da planta
BR112015012926A2 (pt) uso de 1-(aril etinil)-, 1-(heteroaril etinil)-, 1-(heterociclil etinil)- substituído e 1-(cicloalquenil etinil)-ciclohexanóis como agentes ativos contra o estresse abiótico da planta
Abajue et al. Diversity of medicinal plants used in the treatment and management of viral diseases transmitted by mosquitoes in the tropics
Black et al. Seasonal variation of phenolic constituents and medicinal activities of Northern Labrador tea, Rhododendron tomentosum ssp. subarcticum, an Inuit and Cree First Nations traditional medicine
AR083594A1 (es) Composiciones para el tratamiento de ulceras perifericas de varios origenes
CL2012002893A1 (es) Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales.
Manzano-Santana et al. Potential bioactive compounds of medicinal plants against new Coronavirus (SARS-CoV-2): A review
Wróblewski et al. Antioxidant potential of medicinal plants in the treatment of Scabies infestation
AR083215A1 (es) Combinacion sinergica de abamectina y bifentrina, su proceso de preparacion y uso, y metodo utilizando la misma
Koubala et al. Evaluation of Insecticide Properties of Ethanolic Extract from" Balanites aegyptiaca"," Melia azedarach" and" Ocimum gratissimum" leaves on" Callosobruchus maculatus"(Coleptera: Bruchidae)
Subramanium Evaluation of anti†inflammatory and analgesic activities of methanolic leaf extract of the endangered tree species, Hildegardia populifolia (Roxb.) Schott and Endl
BRPI0702622A8 (pt) Composições farmacêuticas com atividade antifúngica contendo extratos de cymbopogon nardus, processo de obtenção dos extratos de cymbopogon nardus e seus usos
Afzal et al. Efficacy of Avicennia marina (Forsk.) Vierh. leaves extracts against some atmospheric fungi
BRPI1013612A8 (pt) composição pesticida tópica, seu método de tratamento com pesticida de culturas vegetais e uso de piretroide e um biocida de organofosfato
Adoum et al. Phytochemicals and hypoglycaemic effect of methanol stem-bark extract of Ficus sycomorus Linn (Moraceae) on alloxan induced diabetic Wistar albino rats
BR112015030196A2 (pt) derivados de 5-hidróxi-2,3-difenilpentanonitrila substituída, processos para sua preparação e seu uso como herbicidas e/ou reguladores de crescimento de planta
Timothy et al. Antibacterial and phytochemical screening of the ethanolic leaf extract of azadirachta indica (neem)(meliaceae).
Mussin et al. Inhibitory activity of Conyza bonariensis (L.) Cronquist tincture against fungi and bacteria causing superficial infections
BR112015004859A2 (pt) utilização de ácidos 2,3-di-hidro-1-benzofurano-4-carboxílicos ou seus sais como substâncias ativas contra stress abiótico em plantas
Shyamjith et al. Effect of Tylophora indica on Haloperidol Induced Catalepsy in Experimental Animal Models.

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: APSEN FARMACEUTICA S.A. (BR/SP) , UNIVERSIDADE EST

Free format text: A FIM DE ATENDER A(S) TRANSFERENCIA(S), REQUERIDA(S) ATRAVES DA PETICAO NO 151400, DE 25/02/2014, E NECESSARIO REAPRESENTAR O DOCUMENTO DE CESSAO COM AS FIRMAS DOS REPRESENTANTES DAS PARTES ENVOLVIDAS DEVIDAMENTE RECONHECIDAS, CONFORME ART. 9O, DO DECRETO NO 6.932, DE 11/08/2009. OUTROSSIM, E PRECISO QUE SEJA JUNTADO COMPROVANTE DE QUE A REPRESENTANTE DA CEDENTE TEM PODERES PARA ALIENAR BENS, BEM COMO RECOLHER A GUIA RELATIVA A ESTA EXIGENCIA.

B25A Requested transfer of rights approved

Owner name: UNIVERSIDADE ESTADUAL DE MARINGA (BR/PR)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL